ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.720
+0.400 (30.30%)
May 14, 2025, 11:21 AM - Market open

ADC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
1711921343071,5502,485
Upgrade
Market Cap Growth
-62.30%43.49%-56.31%-80.20%-37.60%-
Upgrade
Enterprise Value
3853732592641,3402,030
Upgrade
Last Close Price
1.321.991.663.8420.2032.01
Upgrade
PS Ratio
1.812.721.931.4645.71-
Upgrade
PB Ratio
-0.55-0.95-0.903.869.347.41
Upgrade
P/TBV Ratio
---3.8610.127.64
Upgrade
EV/Sales Ratio
5.075.263.731.2639.51-
Upgrade
Debt / Equity Ratio
-1.88-2.19-2.894.151.970.13
Upgrade
Asset Turnover
0.260.210.170.380.06-
Upgrade
Inventory Turnover
6.896.699.1816.36--
Upgrade
Quick Ratio
3.923.374.494.886.7510.90
Upgrade
Current Ratio
4.463.824.975.317.1011.14
Upgrade
Return on Equity (ROE)
----127.99%-91.72%-110.28%
Upgrade
Return on Assets (ROA)
-27.02%-24.13%-24.54%-13.91%-28.91%-42.03%
Upgrade
Return on Capital (ROIC)
-34.85%-31.40%-30.12%-17.08%-37.57%-55.48%
Upgrade
Earnings Yield
-114.46%-82.03%-179.01%-51.19%-14.84%-9.91%
Upgrade
FCF Yield
-95.25%-64.81%-90.91%-45.28%-15.27%-6.82%
Upgrade
Buyback Yield / Dilution
-18.91%-18.91%-4.55%-1.83%-17.33%-32.73%
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q